Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations
Overview
Affiliations
The CRISPR/Cas9 system is a popular genome-editing tool with immense therapeutic potential. It is a simple two-component system (Cas9 protein and RNA) that recognizes the DNA sequence on the basis of RNA:DNA complementarity, and the Cas9 protein catalyzes the double-stranded break in the DNA. In the past decade, near-atomic resolution structures at various stages of the CRISPR/Cas9 DNA editing pathway have been reported along with numerous experimental and computational studies. Such studies have boosted knowledge of the genome-editing mechanism. Despite such advancements, the application of CRISPR/Cas9 in therapeutics is still limited, primarily due to off-target effects. Several studies aim at engineering high-fidelity Cas9 to minimize the off-target effects. Molecular Dynamics (MD) simulations have been an excellent complement to the experimental studies for investigating the mechanism of CRISPR/Cas9 editing in terms of structure, thermodynamics, and kinetics. MD-based studies have uncovered several important molecular aspects of Cas9, such as nucleotide binding, catalytic mechanism, and off-target effects. In this Review, the contribution of MD simulation to understand the CRISPR/Cas9 mechanism has been discussed, preceded by an overview of the history, mechanism, and structural aspects of the CRISPR/Cas9 system. These studies are important for the rational design of highly specific Cas9 and will also be extremely promising for achieving more accurate genome editing in the future.
Solid-State Nanopore Real-Time Assay for Monitoring Cas9 Endonuclease Reactivity.
Chau C, Weckman N, Thomson E, Actis P ACS Nano. 2025; 19(3):3839-3851.
PMID: 39814565 PMC: 11781028. DOI: 10.1021/acsnano.4c15173.
CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis.
Gu B, Li M, Li D, Huang K J Cardiovasc Transl Res. 2025; .
PMID: 39804565 DOI: 10.1007/s12265-024-10587-7.
Fatemi Abhari S, Di Felice R ACS Omega. 2024; 9(45):44974-44988.
PMID: 39554421 PMC: 11561601. DOI: 10.1021/acsomega.4c04359.
CRISPR/Cas technology: fueling the future of Biofuel production with sugarcane.
Ghane A, Malhotra P, Sanghera G, Verma S, Jamwal N, Kashyap L Funct Integr Genomics. 2024; 24(6):205.
PMID: 39495322 DOI: 10.1007/s10142-024-01487-9.
Allemailem K, Almatroudi A, Alrumaihi F, Alradhi A, Theyab A, Algahtani M Int J Nanomedicine. 2024; 19:10185-10212.
PMID: 39399829 PMC: 11471075. DOI: 10.2147/IJN.S479068.